Doctor Miguel Frias
Geneva University Hospitals, Geneva (Switzerland)
HIV-infected patients display increased proatherogenic anti-apolipoprotein A1 autoantibodies, inflammatory and metabolomic markers
Event: ESC Congress 2021 - The Digital Experience
Topic: HIV and Cardiovascular Disease
Session: Cardiovascular Disease in Special Populations ePosters
Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients
Event: ESC Congress 2020
Topic: HIV and Cardiovascular Disease
Session: Inflammatory and Infectious Disorders and Heart Disease
The presence of anti-apolipoprotein A1 autoantibodies is associated with a pro-atherogenic profile in HIV-infected patients.
Event: ESC Congress 2019
Topic: HIV and Cardiovascular Disease
Session: Immunodeficiency virus (HIV)
ESC 365 is supported by
